61 |
H. Lee, M.-Y. Lee, S. H. Bhang, B.-S. Kim, Y. S. Kim, J. H. Ju, K. S. Kim, and S. K. Hahn*, "Hyaluronate - Gold Nanoparticle / Tocilizumab Complex for the Treatment of Rheumatoid Arthritis", ACS Nano, 8, 4790-4798 (2014) (Impact factor: 17.1).
|
62 |
H. S. Jung, W. H. Kong, D. K. Sung, M. Y. Lee, S. E. Beack, D. H. Keum, K. S. Kim, S. H. Yun, and S. K. Hahn*, "Nanographene Oxide - Hyaluronic Acid Conjugate for Photothermal Ablation Therapy of Skin Cancer", ACS Nano, 8, 260-268 (2014) (Impact factor:17.1) - Highlighted in the Chemical and Engineering News.
|
63 |
M. Choi, J. W. Choi, S. Kim, S. Nizamoglu, S. K. Hahn, and S. H. Yun*, "Light-Guiding Hydrogels for Cell-Based Sensing and Optogenetic Synthesis in vivo", Nature Photonics, 7, 987-994 (2013) (Impact factor: 35.0) - Highlighted in Nature Photonics News and Nature Reviews Endocrinology.
|
64 |
H. Kim, H. T. Park, Y. M. Tae, W. H. Kong, D. K. Sung, B. W. Hwang, K. S. Kim, Y. K. Kim*, and S. K. Hahn*, "Bioimaging and Pulmonary Applications of Self-Assembled Flt1 Peptide - Hyaluronic Acid Conjugate Nanoparticles", Biomaterials, 34, 8478-8490 (2013) (Impact factor: 14.0).
|
65 |
D. K. Sung, W. H. Kong, K. Park, J. H. Kim, M. Y. Kim, H. Kim, S. K. Hahn*, "Noncovalenly PEGylated CTGF siRNA/PDMAEMA Complex for Pulmonary Treatment of Bleomycin-Induced Lung Fibrosis", Biomaterials, 34, 1261-1269 (2013) (Impact factor: 14.0).
|
66 |
W. H. Kong, K. Park, M.-Y. Lee, H. Lee, D. K. Sung, S. K. Hahn*, "Cationic Solid Lipid Nanoparticles Derived from Apolipoprotein-free LDLs for Target Specific Systemic Treatment of Liver Fibrosis", Biomaterials, 34, 542-551 (2013) (Impact factor: 14.0).
|
67 |
M.-Y. Lee, J.-A. Yang, H. S. Jung, S. Beack, J. E. Choi, W. Hur, H. Koo, K. Kim, S. K. Yoon, and S. K. Hahn*, "Hyaluronic Acid - Gold Nanoparticle / Interferon α Complex for Targeted Treatment of Hepatitis C Virus Infection", ACS Nano, 6, 9522-9531 (2012) (Impact factor:17.1).
|
68 |
H. Koo, S. Lee, J. H. Na, S. H. Kim, S. K. Hahn, K. W. Choi, I. C. Kwon, S. Y. Jeong, and K. Kim*, "Bioorthogonal Copper-Free Click Chemistry In Vivo for Tumor-targeted Delivery of Nanoparticles", Angew. Chem. Intern. Ed., 51, 11836-11840 (2012) (Impact factor: 16.6).
|
69 |
H. Kim, J.-S. Choi, K. S. Kim, J.-A. Yang, C.-K. Joo*, S. K. Hahn*, "Flt1 Peptide-Hyaluronate Conjugate Micelle-Like Nanoparticles Encapsulating Genistein for the Treatment of Occular Neovascularization", Acta Biomaterialia, 8, 3932-3940 (2012) (Impact factor: 9.7).
|
70 |
W. H. Kong, D. K. Sung, K. S. Kim, H. S. Jung, E. J. Gho, S. H. Yun, S. K. Hahn*, “Self-Assembled Complex of Probe Peptide - E. Coli RNA I Conjugate and Nano Graphene Oxide for Apoptosis Diagnosis”, Biomaterials, 33, 7556-7564 (2012) (Impact factor: 14.0).
|
71 |
J.-A. Yang, E.-S. Kim, J. H. Kwon, H. Kim, J. H. Shin, S. H. Yun, K. Y. Choi*, S. K. Hahn*, “Transdermal Delivery of Hyaluronic Acid - Human Growth Hormone Conjugate”, Biomaterials, 33, 5947-5954 (2012) (Impact factor: 14.0).
|
72 |
K. M. Park, J.-A. Yang, H. Jung, J. Yeom, J. S. Park, K.-H. Park, A. S. Hoffman, S. K. Hahn*, and K. Kim*, “In Situ Supramolecular Assembly and Modular Modification of Hyaluronic Acid Hydrogels for 3D Cellular Engineering”, ACS Nano, 6, 2960-2968 (2012) (Impact factor: 17.1) - Highlighted in the ECM News.
|
73 |
J.-A. Yang, K. Park, H. Jung, H. Kim, S. W. Hong, S. K. Yoon, S. K. Hahn*, “Target Specific Hyaluronic Acid - Interferon Alpha Conjugate for the Treatment of Hepatitis C Virus Infection”, Biomaterials, 32, 8722-8729 (2011) (Impact factor: 14.0).
|
74 |
M.-Y. Lee, S.-J. Park, K. Park, K. S. Kim, H. Lee, and S. K. Hahn*, “Target Specific Gene Silencing of Layer-by-Layer Assembled Gold-Cysteamine/siRNA/PEI/HA Nanocomplex”, ACS Nano, 5, 6138-6147 (2011) (Impact factor: 17.1).
|
75 |
H. Jung, K. M. Park, J.-A. Yang, E. J. Oh, D.-W. Lee, K. Park, S. H. Ryu, S. K. Hahn*, K. Kim*, “ Theranostic Systems Assembled In Situ On Demand by Host-Guest Chemistry”, Biomaterials, 32, 7687-7694 (2011) (Impact factor: 14.0).
|
76 |
J. K. Park, J.-H. Shim, K. S. Kang, J. Yeom, H. S. Jung, J. Y. Kim, K. H. Lee, T.-H. Kim, S.-Y. Kim, D.-W. Cho*, and S. K. Hahn*, "Solid Free-Form Fabrication of Tissue-Engineering Scaffolds with a Poly(lactec-co-glycolic acid) Grafted Hyaluronic Acid Conjugate Encapsulating an Intact Bone Morphogenetic Protein-2/Poly(ethylene glycol) Complex", Advanced Functional Materials, 21, 2906-2912 (2011) (Impact factor: 19.0).
|
77 |
K. Park, S. W. Hong, W. Hur, M.-Y. Lee, J.-A. Yang, S. W. Kim, S. K. Yoon*, and S. K. Hahn*, “Target Specific Systemic Delivery of TGF-β siRNA/(PEI-SS)-g-HA Complex for the Treatment of Liver Cirrhosis”, Biomaterials, 32, 4951-4958 (2011) (Impact factor: 14.0).
|
78 |
E. J. Oh, J.-S. Choi, H. Kim, C.-K. Joo*, and S. K. Hahn*, “Anti Flt1 Peptide-Hyaluronate Conjugate for the Treatment of Retinal Neovascularization and Diabetic Retinopathy”, Biomaterials, 32, 3115-3123 (2011) (Impact factor: 14.0).
|
79 |
K. S. Kim, S. J. Park, J.-A. Yang, J.-H. Jeon, S. H. Bhang, B.-S. Kim, S. K. Hahn*, " Injectable Hyaluronic Acid - Tyramine Hydrogels for the Treatment of Rheumatoid Arthritis", Acta Biomaterialia, 7, 666-674 (2011) (Impact factor: 9.7).
|
80 |
E. J. Oh, K. Park, K. S. Kim, J. Kim, J.-A. Yang, J.-H. Kong, M. Y. Lee, A. S. Hoffman, and S. K. Hahn*, “Target Specific and Long-Acting Delivery of Protein, Peptide, and Nucleotide Therapeutics Using Hyaluronic Acid Derivatives”, Journal of Controlled Release, 141, 2-12 (2010) (Impact factor: 10.8).
|